Notice of Special Interest (NOSI) Targeting Epigenetic Regulators for Treating Addiction and Substance Use Disorders
Department of Health and Human Services ▸ National Institutes of Health ▸
Description
This grant opportunity invites researchers to conduct basic preclinical studies on enzymes and pathways involved in epigenetic changes caused by addictive drugs. The research aims to develop new drugs, methods, and treatments for substance use disorders and addiction.
The goal of this announcement is to encourage basic preclinical research aimed at identifying and targeting specific enzymes and pathways that play a key role in epigenetic changes induced by addictive drugs with the goal of developing pharmacological tools, methods, and therapeutic intervention…
Source
Grant ID
NOT-DA-24-004
Funding Source
Department of Health and Human Services ▸ National Institutes of Health ▸
Key Dates
Opportunity Released
November 3, 2022
Similar opportunities
- Notices of Special Interest (NOSI): High Priority Areas in Genetics, Epigenetics, and Developmental Neuroscience Branch in the Division of Neuroscience and Behavior
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
- Collaborative Research on Substance Use Disorders
- Notice of Special Interest (NOSI): Chemoproteomic Approaches for Discovery of Targets and Therapeutics to Treat Substance Use Disorders
- Notice of Special Interest (NOSI): Development and Application of Novel Chemical Approaches to Discover Therapeutic Targets for Substance Use Disorders